Lucintel Forecasts The Global Subcutaneous Drug Delivery Device Market To Reach $50 Billion By 2030

By Author: Lucintel LLC
Total Articles: 6657
Comment this article

According to the recent study the subcutaneous drug delivery device market is projected to reach an estimated $50 billion by 2030 from $25 billion in 2023 at a CAGR of 11% from 2023 to 2030. Growth in this market is primarily driven by increasing number of cases for diabetes and cardiovascular diseases (CVD) and expanding use of these delivery systems for various biomedical drug advances and immunisation campaign.
A more than 150–page report is developed to understand trends, opportunities and forecast in subcutaneous drug delivery device market by product (prefilled syringes, pen injectors, auto-injectors, wearable injectors, and needle-free injectors), distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)
Lucintel forecasts that prefilled syringes will remain the largest segment over the forecast period due to its expanding usage because of its easy-to-use features, easily availability, cost effectiveness, and high societal acceptance.
Retail pharmacy is expected to remain the largest segment due ...
... to patients’ growing preference for physical pharmacies owing to quick availability of medication and expanding number of retail pharmacies.
Download sample by clicking on subcutaneous drug delivery device market
North America will remain the largest region due to presence of advanced healthcare infrastructure, introduction of needle-free subcutaneous drug delivery device, and growing number of chronic disease cases in the region.
Gerresheimer, Medtronic, Ypsomed, Elcam Medical Group, and Novo Nordisk are among the major subcutaneous drug delivery device market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Natural Angelica Extract Ligustilide Market
Silodosin Capsule Market
Technical Nonwoven Market
Consumer to Consumer E-Commerce Market
Automatic Chain Lubrication System Market
R290 (Propane) Market